Your browser doesn't support javascript.
loading
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses.
Taylor, David; Meyer, Christian T; Graves, Diana; Sen, Rupashree; Fu, Juan; Tran, Emily; Mirza, Bilal; Rodriguez, Gabriel; Lang, Cara; Feng, Hanwen; Quaranta, Vito; Wilson, John T; Kim, Young J; Korrer, Michael J.
Afiliação
  • Taylor D; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Meyer CT; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO, United States.
  • Graves D; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Sen R; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Fu J; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Tran E; College Arts and Sciences, Vanderbilt University, Nashville, TN, United States.
  • Mirza B; Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Rodriguez G; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Lang C; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Feng H; Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Quaranta V; Department of Biochemistry, Vanderbilt University, Nashville, TN, United States.
  • Wilson JT; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States.
  • Kim YJ; Oncology Chair, Global Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
  • Korrer MJ; Department of Otolaryngology Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, United States.
Front Immunol ; 13: 936129, 2022.
Article em En | MEDLINE | ID: mdl-36059502

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article